Model System Using Controlled Receptor Expression for Evaluating Targeted Ultrasound Contrast Agents

Ultrasound in Medicine and Biology

Volumn 37, Issue 8, 2011, Pages 1306-1313

  Saini, Reshu ^a   Warram, Jason M ^b   Sorace, Anna G ^a   Umphrey, Heidi ^c   Zinn, Kurt R ^c,d   Hoyt, Kenneth ^a,c,d  

^a and Radiation Oncology   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adenoviral vectors; Contrast enhanced ultrasound imaging; Microbubbles; Modulated receptors

Indexed keywords

ADENOVIRAL VECTORS; BREAST CANCER CELLS; CELL BINDING; CELL SURFACES; CONTRAST AGENT; CONTRAST ENHANCED ULTRASOUND; GFP EXPRESSION; GREEN FLUORESCENT PROTEIN; IN-VITRO; MICROBUBBLES; MODEL SYSTEM; MODULATED RECEPTORS; MULTIPLICITY OF INFECTIONS; NON-SPECIFIC BINDING; RECEPTOR EXPRESSION; REPORTER GENE; STREPTAVIDIN; TARGET RECEPTOR; ULTRASOUND CONTRAST AGENT;

CELL MEMBRANES; FLOW CYTOMETRY; GENE TRANSFER; PROTEINS; ULTRASONIC IMAGING; ULTRASONICS;

GENE EXPRESSION;

ADENOVIRUS VECTOR; BIOTIN; ECHO CONTRAST MEDIUM; GREEN FLUORESCENT PROTEIN; HEMAGGLUTININ; RECEPTOR; RECEPTOR ANTIBODY; STREPTAVIDIN;

ANTIGEN BINDING; ARTICLE; BIOTINYLATION; CANCER CELL CULTURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOMEGALOVIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROBUBBLE; MOLECULAR IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; REPORTER GENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; CELL LINE, TUMOR; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; FEMALE; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HEMAGGLUTININS; HUMANS; IMAGE ENHANCEMENT; MAMMARY NEOPLASMS, EXPERIMENTAL; MICROBUBBLES; NEOVASCULARIZATION, PATHOLOGIC;

EID: 79959848479     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2011.05.010     Document Type: Article

References (27)

1. Anderson C.R., Rychak J.J., Backer M., Backer J., Ley K., Klibanov A.L. scVEGF microbubble ultrasound contrast agents: A novel probe for ultrasound molecular imaging of tumor angiogenesis. Invest Radiol 2010, 45:579-585.
2. Behm C.Z., Kaufmann B.A., Carr C., Lankford M., Sanders J.M., Rose C.E., Kaul S., Lindner J.R. Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation 2008, 117:2902-2911.
3. Christiansen J.P., Leong-Poi H., Klibanov A.L., Kaul S., Lindner J.R. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation 2002, 105:1764-1767.
4. 3. Circulation 2003, 108:336-341.
5. Floyd E., McShane T.M. Development and use of biomarkers in oncology drug development. Toxicol Pathol 2004, 32:106-115.
6. Friedlander M., Brooks P.C., Shaffer R.W., Kincaid C.M., Varner J.A., Cheresh D.A. Definition of two angiogenic pathways by distinct alpha-v integrins. Science 1995, 270:1500-1502.
7. Hurwitz H., Fehrenbacher L., Novotny W., Catwright T., Hainsworth J., Heim W., Berlin J., Baron A., Griffin S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross R., Kabbinavar F. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350:2335-2342.
8. Kaufmann B.A., Lindner J.R. Molecular imaging with targeted contrast ultrasound. Curr Op Biotech 2007, 18:11-16.
9. Kaufmann B.A., Carr C.L., Belcick J.T., Xie A., Yue Q., Chadderdon S., Caplan E.S., Khangura J., Bullens S., Bunting S., Lindner J.R. Molecular imaging of the initial inflammatory response in atherosclerosis: Implications for early detection of disease. Aterioscler Thromb Vasc Bio 2009, 30:54-59.
10. Klibanov A.L. Ligand -carrying gas-filled microbubbles: Ultrasound contrast agents for targeted molecular imaging. Bioconjugate Chem 2005, 16:9-17.
11. Klibanov A.L., Rychak J.J., Yang W.C., Alikhani S., Li B., Acton S., Lindner J.R., Ley K., Kaul S. Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media Mol Imaging 2006, 1:259-266.
12. Knowles J.A., Heath C.H., Saini R., Umphrey H., Zinn K.R., Hoyt K. Molecular targeting of ultrasound contrast agent enhances detection of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2011, in press.
13. Korpanty G., Carbon J.G., Grayburn P.A., Fleming J.B., Brekken R.A. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res 2007, 13:323.
14. Leighton T.G. The Acoustic Bubble 1997, Academic Press, London.
15. Leong -Poi H., Christiansen J., Klibanov A.L., Kaul S., Lindner J.R. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha-v integrins. Circulation 2002, 107:455-460.
16. Lindner J.R., Song J., Christiansen J., Klibanov Al, Xu F., Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001, 104:2107-2112.
17. Lindner J.R. Microbubbles in medical imaging: Current applications and future directions. Nat Rev 2004, 4:527-532.
18. Lindner J.R. Contrast ultrasound molecular imaging of inflammation in cardiovascular disease. Cardiovasc Res 2009, 84:182-189.
19. Lyshchik A., Fleisher A.C., Huamani J., Hallahan D.E., Brissova M., Gore J.C. Molecular Imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. J Ultrasound Med 2007, 26:1575-1586.
20. Miller K., Wang M., Gralow J., Dickler M., Cobleigh M., Perez E.A., Shenkier T., Cella D., Davidson N.E. Paclitaxel plus Bevacizumab versus Paclitaxel alone for metastatic breast cancer. N Engl J Med 2007, 357:2666-2676.
21. Unger E.C., McCreery T.P., Sweitzer R.H., Shen D., Wu G. In vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol 1998, 81:58-61.
22. Warram J.M., Sorace A.G., Saini R., Umphrey H., Zinn K.R., Hoyt K. Triple-targeted US contrast agent provides improved localization to tumor vasculature. J Ultrasound Med 2011, in press.
23. Weller G.E., Villanueva F.S., Klibanov A.L., Wagner W.R. Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium. Ann Biomed Eng 2002, 30:1012-1019.
24. Willmann J.K., Paulmurugan R., Chen K., Gheysens O., Rodriguez-Porcel M., Lutz A.M., Chen I.Y., Chen X., Gambhir S.S. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 2008, 246:508-518.
25. Willmann J.K., Kimura R.H., Deshpande N., Lutz A.M., Cochran J.R., Gambhir S.S. Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides. J Nuclear Med 2010, 51:433-440.
26. Wu E., Nemerow G.R. Virus yoga: The role of flexibility in virus host cell recognition. Trends Microbiol 2004, 12:162-169.
27. Zinn K.R., Chaudhuri T.R., Krasnykh V.N., Buchsbaum D.J., Belousova N., Grizzle W.E., Curlel D.T., Rogers B.E. Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice. Radiology 2002, 223:417-425.